TG Therapeutics | Capitale Sociale E Riserve



Equity Capital And Reserves Cambiamento Data
AbbVie USD 1.46B 1.86B 2025-03
Alaunos Therapeutics USD 2.06M 661K 2024-12
Amgen USD 7.43B 1.22B 2025-06
Ardelyx USD 139.53M 33.76M 2025-06
Arrowhead Research USD 522.31M 161.91M 2025-06
Bayer EUR 30.5B 2.08B 2025-06
Biogen USD 17.63B 655.3M 2025-06
Corcept Therapeutics USD 635.79M 47.49M 2025-06
Dynavax Technologies USD 494.16M 36.78M 2025-06
Gilead Sciences USD 19.67B 596M 2025-06
J&J USD 78.11B 6.62B 2025-03
Novartis USD 42.05B 3.6B 2025-06
PTC Therapeutics USD -206546000 20.79M 2025-06
Regeneron Pharmaceuticals USD 29.94B 551.3M 2025-06
Roche Holding CHF 36.16B 3.28B 2024-12
TG Therapeutics USD 276.43M 39.14M 2025-06
Vertex Pharmaceuticals USD 17.18B 679.1M 2025-06


TG Therapeutics Capitale Sociale E Riserve - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - Sep 2025.